Pericapsular Nerve Group Block vs Interscalene Block for Shoulder Arthroscopy

Launched by CAIRO UNIVERSITY · Jan 5, 2024

Keywords

ClinConnect Summary

This clinical trial is looking to compare two different methods of providing anesthesia for patients undergoing shoulder surgery called arthroscopy. The two techniques being studied are the Pericapsular Nerve Group (PENG) block and the Interscalene Block (ISBP). The researchers want to find out which method results in fewer side effects, better pain control after surgery, and how quickly patients need pain relief after the procedure.

To be eligible for this study, participants need to be between 18 and 60 years old and scheduled for shoulder arthroscopy. They should generally be in good health, classified as ASA I or II, which means they have minimal or no systemic disease. However, individuals with certain health issues, such as bleeding disorders, infections at the injection site, or severe heart and lung conditions, will not be included. If you join the trial, you will receive one of the two anesthesia methods, and the team will monitor your pain levels and any side effects you may experience. This study aims to improve the way pain is managed during and after shoulder surgeries.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients scheduled for shoulder arthroscopy
• • American Society of Anesthesiologists (ASA) status I and II
• • Ages between 18 and 60 years.
• Exclusion Criteria:
• • Coagulopathy
• • Infection at the injection site.
• • Allergy to local anesthetics
• • Severe cardiopulmonary disease (≥ASA III)
• • Diabetic or other neuropathies
• • Motor disorders
• • Patients receiving opioids for chronic analgesic therapy.
• • Inability to comprehend visual analogue scale (VAS).